Clinical Trials Directory

Trials / Terminated

TerminatedNCT00492479

An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
Sponsor
Innovative Medical · Industry
Sex
Female
Age
35 Years – 55 Years
Healthy volunteers

Summary

The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.

Conditions

Interventions

TypeNameDescription
DRUGKinerase Pro+Therapy Line day repair, serum, night repair
DRUGKinerase Pro+Therapy Line Ultra rich day repair
DRUGLubriDerm

Timeline

Start date
2007-06-01
Completion
2007-12-01
First posted
2007-06-27
Last updated
2007-12-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00492479. Inclusion in this directory is not an endorsement.